At Acres Biosciences, we provide specialized in vitro, in vivo, and ex vivo neuroscience services to accelerate the discovery and development of therapies for neurodegenerative and neuroinflammatory diseases. Our team integrates advanced cellular models with translational in vivo systems to deliver data that supports decision-making in early discovery and preclinical development.
We specialize in cellular assays, organoid systems, and pharmacology studies that recapitulate key aspects of CNS biology. Our flexible platform supports customizable study designs across Alzheimer’s, Parkinson’s, ALS, multiple sclerosis, and other neurological disorders.